Eosinophilic Myositis: Workup and Treatment
For eosinophilic myositis, obtain a muscle biopsy with immunostaining for eosinophil major basic protein to confirm diagnosis, exclude secondary causes (parasites, drugs, malignancy, hypereosinophilic syndrome), and initiate glucocorticoids as first-line therapy.
Diagnostic Workup
Essential Diagnostic Steps
Muscle biopsy is mandatory and remains the cornerstone for diagnosis 1. Standard histologic examination may miss infiltrating eosinophils, so specifically request immunostaining for eosinophil major basic protein, which is the hallmark of eosinophilic cytotoxicity and is usually detected even when eosinophils themselves are not visible 1.
Identify the Subtype
Recognize that eosinophilic myositis has three distinct subtypes with different implications 1:
- Focal eosinophilic myositis: Benign, isolated condition affecting single or multiple muscle groups
- Eosinophilic polymyositis: More serious; can be associated with muscular dystrophy or hypereosinophilic syndrome
- Eosinophilic perimyositis: Usually related to fasciitis
Critical Secondary Cause Exclusion
Before labeling as idiopathic, systematically exclude 1:
- Parasitic infections (stool studies, serologies)
- Drugs and toxic substances (detailed medication history)
- Connective tissue disorders (autoantibody panel, clinical features)
- Hematologic malignancies (CBC with differential, peripheral smear)
- Non-hematologic malignancies (age-appropriate cancer screening)
- Hypereosinophilic syndrome (absolute eosinophil count >1,500/μL with end-organ damage)
Additional Workup Elements
- Serum creatine kinase: Often elevated
- Peripheral eosinophil count: May show eosinophilia but not always
- MRI of affected muscles: Useful for identifying biopsy sites and monitoring treatment response 2
- EMG: May show myopathic changes 2
- Serum IgE: High levels may be a marker of eosinophilic myositis 3
Important Pitfall
Consider underlying muscular dystrophy if the patient fails to respond to immunosuppression or shows progressive weakness despite treatment. One case demonstrated that eosinophilic myositis can be a secondary phenomenon in limb-girdle muscular dystrophy 4. If clinical suspicion arises, pursue genetic testing for muscular dystrophies.
Treatment Algorithm
First-Line Therapy for Idiopathic Forms
Glucocorticoids are the mainstay therapy for idiopathic eosinophilic myositis 1. Based on inflammatory myopathy treatment principles:
- Initial regimen: High-dose corticosteroids (prednisone 1 mg/kg/day, up to 60 mg/day) 2
- Add steroid-sparing agent early: Methotrexate, azathioprine, or mycophenolate mofetil to allow corticosteroid tapering 2
- Taper corticosteroids after 2-4 weeks depending on response 2
Refractory or Severe Disease
For patients with extensive disease, multiorgan involvement, or inadequate response to standard therapy:
- High-dose methylprednisolone (intravenous pulse therapy) 2
- Intravenous immunoglobulin (IVIG) 2
- Cyclophosphamide, rituximab, or cyclosporine for severe cases 2
- Tocilizumab: Emerging evidence shows benefit in refractory focal eosinophilic myositis, particularly with extra-ocular muscle involvement 5
Hypereosinophilic Syndrome-Associated Myositis
If eosinophilic myositis is part of hypereosinophilic syndrome:
- Imatinib: Particularly if FIP1L1-PDGFRA fusion gene is present 1
- Mepolizumab: Humanized anti-IL-5 monoclonal antibody may be useful 1
Treatment Response Monitoring
- Clinical assessment: Muscle strength, functional capacity
- Serum CK levels: Should decrease with effective treatment
- MRI: Can monitor treatment response 2
- Consider novel biomarkers: IL-6 and type 1 interferon-regulated genes may indicate disease activity 2
Critical Clinical Caveats
Vasculitis association: Eosinophilic myositis can occur with vasculitis and polyneuropathy 6. If present, this suggests a more systemic process requiring aggressive immunosuppression.
Esophageal involvement: If dysphagia is prominent with motility disorders and high IgE, consider eosinophilic esophageal myositis, which may require endoscopic ultrasound with deep biopsy and potentially different management including oral steroids or even Per-Oral Endoscopic Myotomy (POEM) 3, 7, 8.
Treatment resistance: If standard immunosuppression fails, reassess for secondary causes (especially occult malignancy or underlying dystrophy) before escalating to biologics 4, 5.